Therapeutics

Developing drugs that target novel biological pathways

Learn More

Bioprocessing

Products to enhance manufacturing efficiency and economics

Learn MoreOrder Now

Repligen welcomes Novozymes Biopharma’s Cell Growth Factors to our family of manufacturing products--click here for an overview.

Highlights

  • Dec 21, 2011:   Repligen Announces Submission of New Drug Application for SecreFlo™ for Improved Pancreatic Imaging In Patients with Pancreatitis   More
  • Dec 20, 2011:   Repligen Completes Acquisition of Novozymes Biopharma Sweden AB   More
  • Oct 27, 2011:   Repligen Acquires Business of Novozymes Biopharma Sweden AB   More